These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37996794)

  • 1. Risk factors associated with newly diagnosed attention-deficit/hyperactivity disorder in adults: a retrospective case-control study.
    Schein J; Cloutier M; Gauthier-Loiselle M; Bungay R; Arpin E; Guerin A; Childress A
    BMC Psychiatry; 2023 Nov; 23(1):870. PubMed ID: 37996794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health care resource utilization and costs associated with psychiatric comorbidities in adult patients with attention-deficit/hyperactivity disorder.
    Schein J; Cloutier M; Gauthier-Loiselle M; Bungay R; Chen K; Chan D; Childress A
    J Manag Care Spec Pharm; 2024 Jun; 30(6):588-598. PubMed ID: 38824634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real world analysis of treatment change and response in adults with attention-deficit/hyperactivity disorder (ADHD) alone and with concomitant psychiatric comorbidities: results from an electronic health record database study is the United States.
    Liman C; Schein J; Wu A; Huang X; Thadani S; Childress A; Kollins SH; Bhattacharjee S
    BMC Psychiatry; 2024 Sep; 24(1):618. PubMed ID: 39285361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychiatric Comorbidities and Schizophrenia in Youths With Attention-Deficit/Hyperactivity Disorder.
    Jeon SM; Lee DY; Cha S; Kwon JW
    JAMA Netw Open; 2023 Nov; 6(11):e2345793. PubMed ID: 38032637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare resource utilization and costs associated with psychiatric comorbidities in pediatric patients with attention-deficit/hyperactivity disorder: a claims-based case-cohort study.
    Schein J; Cloutier M; Gauthier-Loiselle M; Bungay R; Chen K; Chan D; Guerin A; Childress A
    Child Adolesc Psychiatry Ment Health; 2024 Jul; 18(1):80. PubMed ID: 38978130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comorbidities and costs of adult patients diagnosed with attention-deficit hyperactivity disorder.
    Secnik K; Swensen A; Lage MJ
    Pharmacoeconomics; 2005; 23(1):93-102. PubMed ID: 15693731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in the Prevalence and Incidence of Attention-Deficit/Hyperactivity Disorder Among Adults and Children of Different Racial and Ethnic Groups.
    Chung W; Jiang SF; Paksarian D; Nikolaidis A; Castellanos FX; Merikangas KR; Milham MP
    JAMA Netw Open; 2019 Nov; 2(11):e1914344. PubMed ID: 31675080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical considerations for the evaluation and management of Attention Deficit Hyperactivity Disorder (ADHD) in adults.
    Weibel S; Menard O; Ionita A; Boumendjel M; Cabelguen C; Kraemer C; Micoulaud-Franchi JA; Bioulac S; Perroud N; Sauvaget A; Carton L; Gachet M; Lopez R
    Encephale; 2020 Feb; 46(1):30-40. PubMed ID: 31610922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life and burden of illness in adults with newly diagnosed attention-deficit/hyperactivity disorder in Sweden.
    Ahnemark E; Di Schiena M; Fredman AC; Medin E; Söderling JK; Ginsberg Y
    BMC Psychiatry; 2018 Jul; 18(1):223. PubMed ID: 30005675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health care costs of adults treated for attention-deficit/hyperactivity disorder who received alternative drug therapies.
    Wu EQ; Birnbaum HG; Zhang HF; Ivanova JI; Yang E; Mallet D
    J Manag Care Pharm; 2007 Sep; 13(7):561-9. PubMed ID: 17874862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychiatric comorbidities of adults with early- and late-onset attention-deficit/hyperactivity disorder.
    Lin YJ; Yang LK; Gau SS
    Aust N Z J Psychiatry; 2016 Jun; 50(6):548-56. PubMed ID: 26460330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attention-deficit hyperactivity disorder comorbidity and antidepressant resistance among patients with major depression: A nationwide longitudinal study.
    Chen MH; Pan TL; Hsu JW; Huang KL; Su TP; Li CT; Lin WC; Tsai SJ; Chang WH; Chen TJ; Bai YM
    Eur Neuropsychopharmacol; 2016 Nov; 26(11):1760-1767. PubMed ID: 27667705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The comorbidity of adult attention-deficit/hyperactivity disorder in bipolar disorder patients.
    Karaahmet E; Konuk N; Dalkilic A; Saracli O; Atasoy N; Kurçer MA; Atik L
    Compr Psychiatry; 2013 Jul; 54(5):549-55. PubMed ID: 23306036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comorbidity of adult attention-deficit hyperactivity disorder and bipolar disorder: prevalence and clinical correlates.
    Tamam L; Karakus G; Ozpoyraz N
    Eur Arch Psychiatry Clin Neurosci; 2008 Oct; 258(7):385-93. PubMed ID: 18437277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment Patterns Among Patients with Attention-Deficit/Hyperactivity Disorder and Comorbid Anxiety and/or Depression in the United States: A Retrospective Claims Analysis.
    Schein J; Childress A; Gagnon-Sanschagrin P; Maitland J; Bedard J; Cloutier M; Guérin A
    Adv Ther; 2023 May; 40(5):2265-2281. PubMed ID: 36913128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common psychiatric and metabolic comorbidity of adult attention-deficit/hyperactivity disorder: A population-based cross-sectional study.
    Chen Q; Hartman CA; Haavik J; Harro J; Klungsøyr K; Hegvik TA; Wanders R; Ottosen C; Dalsgaard S; Faraone SV; Larsson H
    PLoS One; 2018; 13(9):e0204516. PubMed ID: 30256837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder.
    Wilens TE; Biederman J; Prince J; Spencer TJ; Faraone SV; Warburton R; Schleifer D; Harding M; Linehan C; Geller D
    Am J Psychiatry; 1996 Sep; 153(9):1147-53. PubMed ID: 8780417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posttraumatic stress disorder in adult attention-deficit/hyperactivity disorder: clinical features and familial transmission.
    Antshel KM; Kaul P; Biederman J; Spencer TJ; Hier BO; Hendricks K; Faraone SV
    J Clin Psychiatry; 2013 Mar; 74(3):e197-204. PubMed ID: 23561240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between attention-deficit/hyperactivity disorder and sleep impairment in adulthood: evidence from a large controlled study.
    Surman CB; Adamson JJ; Petty C; Biederman J; Kenealy DC; Levine M; Mick E; Faraone SV
    J Clin Psychiatry; 2009 Nov; 70(11):1523-9. PubMed ID: 19646365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.